~~<i id='458169BAF3'><strike id='458169BAF3'><tt id='458169BAF3'><pre id='458169BAF3'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

leisure time

author：knowledge 2025-09-02 08:17:00 - browse：578

J.P. Morgan office building at night -- JPM health business coverage from STAT — Adobe

SAN FRANCISCO — Almost three years ago, the country’s biggest bank unveiled a lofty plan to fix the health care industry’s entrenched problems. It broke off $250 million to stand up a new business unit, Morgan Health, to do so.

Today, Morgan Health’s CEO, Dan Mendelson, aided by a newly hired flack, emailed reporters attending that bank’s annual investor confab, the J.P. Morgan Healthcare Conference, asking them for interviews. For the uninitiated, it’s usually the other way around.

Their message? We’re still here.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： Childbirth

explore

leisure time

entertainment

focus

BRENDANSMIALOWSKI/AFPviaGettyImagesAthirdhumancaseofH5birdflutiedtotheongoingU.S.outbreakincattlehas

WSS

Prosthetic arm enables patients to feel the objects they grip

Do more moles mean more problems? Not so, says new study

Eli Lilly, Pfizer, and others want in on the online prescription market

Insmed lung disease drug hits target in key Phase 3 trial

Addiction doctors spar with methadone clinics over legislation

What to make of Gilead’s Trodelvy troubles and Elevation Oncology’s rise

leisure time

leisure time

explore

Medical records are filled with copy

What will save rural psychiatry services? Higher Medicaid payments

Medical records are filled with copy

Elizabeth Holmes banned from government health programs

Bright Health sells Medicare Advantage business to Molina

Heat waves linked to early deliveries, preterm births in new study

The high cost of giving birth even with insurance

Dewpoint Therapeutics lays off staff after losing partnerships

Novavax promises a turnaround & Lilly roils the obesity market

Gene therapies for deafness raise the question: Do deaf people want a 'cure'?

leisure time

Stigma and the return of syphilis

Why doctors need education on FDA device approval process

Readout Newsletter: Insmed, Asahi Kasei, Agios, Royalty Pharma

Latest bird flu infection made farmworker sicker than earlier cases

Readout LOUD podcast: Biotech layoffs, stock slump, 2024 preview

Dark money group runs ads on China biotech bill

leisure time

entertainment

focus

focus